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Background. Origin of electrocardiographic (ECG) alterations during intravascular injection
of local anaesthetic solutions is controversial. The aim of this study was to elucidate whether
epinephrine, bupivacaine or their combination is responsible for ECG alteration.
Methods. Forty-five piglets were randomized into three groups. After induction of general
anaesthesia using sevoflurane and peripheral venous cannulation, the trachea was intubated, the
lungs were artificially ventilated, and anaesthesia was maintained by sevoflurane. Under steady
state 0.2 ml kg21 and after 10 min 0.4 ml kg21 of one of the following three test solutions was
administered i.v.: bupivacaine 0.125% (Group 1), bupivacaine 0.125%þepinephrine 1:200 000
(Group 2), and plain epinephrine 1:200 000 (Group 3). The ECG was analysed for alterations
in heart rate and T-elevation.
Results. After injection of 0.2 or 0.4 ml kg21 test solution, an increase in heart rate of at least
10% was found in none of Group 1 and in all of Groups 2 and 3. After application of 0.2 ml kg21
test solution, T-elevation was found in 7% of Group 1 and in 93% of Groups 2 and 3. The injection
of 0.4 ml kg21 revealed a T-elevation in 27%, 100%, and 100%, respectively, in Groups 1, 2, and 3.
Conclusions. This animal model demonstrated that increases in heart rate and T-elevation in the
ECG during i.v. application of a common test dose (0.2 ml kg21) of bupivacaine are caused by epi-
nephrine addition. Whether higher doses of bupivacaine alone can cause similar ECG changes or
not requires further studies.
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The combination of general anaesthesia and regional
anaesthesia for intra- and postoperative pain relief in chil-
dren is a cornerstone in paediatric anaesthesia, and the
application of regional anaesthesia during general anaes-
thesia is a common practice.1
However, cerebral signs of local anaesthetic (LA) toxicity
due to inadvertent intravascular administration of LAs are
blunted by general anaesthesia, muscle paralysis, or both.
Objective signs and reliable strategies for detection of inad-
vertent intravascular administration of LAs have to be used to
avoid haemodynamic collapse by unrecognized LA
intoxication.
Careful aspiration and passive backflow from the
inserted needle or catheter alone before injecting LA are
not sensitive enough to detect intravascular placement of
the needle or catheter.2 3 Therefore, the addition of
epinephrine to provoke an increase in heart rate has been
recommended.2–4 Monitoring the electrocardiography
(ECG) for detection of LA-related changes, particularly an
increase in T-wave amplitude, is also recommended for
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the early detection of intravascular injection of LAs,2 4–6
although the mechanisms responsible for these ECG
changes have not been clearly elucidated.4
The aim of this study was to determine whether bupiva-
caine, epinephrine, or their combination is responsible for
ECG alterations caused by i.v. administration in a clini-
cally used test dose.
Methods
After obtaining approval from the local Ethics Committee
for Animal Experiments, 45 healthy male and female neo-
natal pigs (up to 6 weeks of age) weighing 4.1–5.9 kg
were included. The pigs had free access to food until 1 h
before anaesthesia induction. Anaesthesia was induced by
the inhalation route using sevoflurane. After establishing a
venous access in an auricular vein, the trachea was intu-
bated then the lungs were artificially ventilated using
pressure-controlled ventilation. Anaesthesia was main-
tained by sevoflurane in oxygen/air 1:1.
Monitoring consisted of pulse oximetry, ECG, end-tidal
(E0) gas analysis (sevoflurane, O2, CO2), and rectal tempera-
ture control. To prevent the pigs from moving, end-tidal
sevoflurane 5 vol% (range 3.7–6.8) was needed. E0CO2 (kPa)
was held between 4.5 and 5. For application of the three
different test solutions, the pigs were randomized into three
groups of 15 individuals. Group 1 received bupivacaine
0.125%, Group 2 bupivacaine 0.125%þepinephrine
1:200 000, and Group 3 plain epinephrine 1:200 000. Under
steady-state conditions 0.2 ml kg21 and 10 min later 0.4 ml
kg21 of the selected test solution were administered i.v. fol-
lowed by a rapid flush of 5 ml normal saline solution. One
ECG lead (lead I, II, or III) was recorded electronically and
continuously printed. The ECG lead was chosen according
to best visibility of P-wave, QRS complex, and a positive
T-wave. Later on an anaesthetist blinded to type of test dose
analysed the ECG print out with particular regard to changes
in heart rate and formation of T-wave elevation. An increase
in heart rate of 10% above baseline, 25% of T-wave
amplitude, or both was considered a positive response.
Randomization was decided by drawing lots. The
Kruskal–Wallis non-parametric tests were performed to
assess differences in the effects on heart rate changes
between the groups followed by post hoc comparisons
using the Bonferroni-corrected Mann–Whitney U-tests.
The effects on T-wave elevation were analysed by Fisher’s
exact test. Computer package SPSS version 16.0 (SPSS
Inc., Chicago, IL, USA) was used. The level of signifi-
cance was set at P0.05.
Results
The median weight of pigs and numbers of males and
females were similar in all groups.
After injection of 0.2 ml kg21 test solution, an increase
in heart rate of 10% was found in 0% in Group 1 and in
100% in Groups 2 and 3 (both P,0.001). Similar results
were observed after injection of 0.4 ml kg21 test solution.
In fact, in Group 1, there was a slight decrease in heart
rate of 25.4% (median) after 0.2 ml kg21 and of 27%
after application of 0.4 ml kg21 test solution.
T-elevation was present in 7% of the piglets in Group 1
and in 93% of the piglets in Groups 2 and 3 after appli-
cation of 0.2 ml kg21 test solution (both P,0.001).
Injection of 0.4 ml kg21 test solution caused T-elevation
in 27%, 100%, and 100%, respectively (both P,0.001). In
most cases, T-elevation started 15–20 s after injection of
the test solution. In all positive cases, T-elevation occurred
within 30 s. A typical ECG trace from each group is
shown in Figure 1. Alterations caused by the different test
solutions are listed in detail in Tables 1 and 2.
Discussion
This study investigated in an animal model whether i.v.
applied epinephrine, bupivacaine, or their combination is
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Fig 1 Representative ECG recordings from each group (n¼15 piglets per group) investigated: (A) pre-injection; and (B) 30 s after injection of test
solution.
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responsible for ECG alteration. The main findings were
that tachycardia and elevation of T-wave amplitude after
i.v. application of a commonly used LA test dose
(0.2 ml kg21) are caused by epinephrine.
Although still debated, the administration of a test dose
of LA is widely used in paediatric regional anaesthesia.4
Test dose sensitivity varies according to the type of LA,
the adjunct drug (epinephrine and isoproterenol), or both.
Furthermore, the type of anaesthetic agents (halothane,
isoflurane, and sevoflurane)7 and whether atropine is admi-
nistered before or not are also important.4 8 We chose
study conditions very close to routine clinical paediatric
anaesthesia; no premedication with atropine, general
anaesthesia with sevoflurane–oxygen–air, bupivacaine as
LA, test dose of 0.2 ml kg21 according to our institutional
guidelines (1 mg kg21 body weight epinephrine,
maximum dose 15 mg per testing dose, which corresponds
a recommended test dose for adults).9–11
Our results clearly demonstrate that the addition of epi-
nephrine into the test dose has a sensitivity of 100% with
regard to tachycardia and 93% with regard to T-elevation
to detect intravascular administration of an LA test dose.
Doubling the dose increased the sensitivity for T-elevation
to 100%.
In the literature, several case series showed a high sensi-
tivity of an epinephrine-containing test solution for heart rate
elevation (positive if 10% increase in heart rate).5 6 8 11–13
But in most of these reports, children were pretreated with
atropine. This is in contrast to modern paediatric anaesthe-
sia practice where atropine is not now routinely used as an
adjunct to premedication, particularly since sevoflurane
was introduced. Interestingly, atropine is known to
enhance heart rate acceleration when epinephrine-
containing test solutions are systemically applied.8
Desparment and colleagues8 found a sensitivity of as low
as 76% without atropine pretreatment, whereas 95% of the
patients showed a tachycardia under the same conditions
(halothane, lidocaineþepinephrine) with 10 mg kg21 atro-
pine injected before the LA test dose. Another important
issue is the fact that in most studies the epinephrine dose
was 0.5 mg kg21 compared with 1 mg kg21 as used in our
set-up. Although we rapidly applied 1 mg kg21 epineph-
rine by the i.v. route, we never observed adverse side-
effects such as ventricular or supraventricular arrhythmias.
This is in accordance with other reports using epinephrine
(usually 0.5 mg kg21).6 14–16
Elevation of T-wave amplitude caused by an inadvertent
intravascular injection of an epinephrine-containing LA test
dose was first described by Freid and colleagues.17 The
mechanisms responsible for these ECG changes were not
previously known. T-wave changes have been found when
only epinephrine,7 LA,18 or both agents together was admi-
nistered.5 6 11 19 In these studies epinephrine and
LAþepinephrine caused T-elevations, even with very small
doses as, for example, test doses. In a report where
T-elevation was caused by the LA, the full dose for a caudal
block was i.v. applied in a 2-month-old infant.18 In our
study, T-elevation caused by a bupivacaine standard test
dose (0.2 ml kg21) occurred in only 7% of the animals and
increased to 27% with the higher test dose (0.4 ml kg21)
applied. Therefore, we suggest that bupivacaine alone can
produce T-elevation, but higher and potentially toxic doses
are required. Under these conditions, bupivacaine without
adjunct cannot serve as a reliable test dose.
The selection of ECG lead during administration of an
epinephrine-containing test dose is not important, as
shown by Ogasawara and colleauges.16 They demonstrated
that there was no significant difference in transient
changes in T-wave amplitude in ECG leads I, II, III, or
V5.
16 These leads were equally effective for detecting
intravascular injection of an epinephrine-containing test
dose in sevoflurane-anaesthetized children.
It is known that an epinephrine-containing test dose
may increase arterial pressure.4 Unfortunately, in our small
pigs, it was very difficult to obtain reliable arterial
pressure values in a non-invasive manner.
Although we have chosen the study conditions as close
to modern paediatric anaesthesia practice as possible and
Table 1 ECG alterations after injection of 0.2 ml kg21 test solution (n¼45 piglets). Results are given in median and range. *P,0.001 between Groups 1 and 2;
#P,0.001 between Groups 1 and 3
Group 1 Group 2 Group 3
Test dose Bupivacaine Bupivacaineþepinephrine Epinephrine
Change in heart rate (beats min21) 27 (218 to 12) 89 (27–116)* 86 (73–127)#
Change in heart rate (% beats min21) 25.4 (213 to 9) 74 (17–101)* 74 (42–123)#
T-elevation (yes/no) 1/14 14/1* 14/1#
Table 2 ECG alterations after injection of 0.4 ml kg21 test solution (n¼45 piglets). Results are given in median and range. *P,0.001 between Groups 1 and 2;
#P,0.001 between Groups 1 and 3
Group 1 Group 2 Group 3
Test dose Bupivacaine Bupivacaineþepinephrine Epinephrine
Change in heart rate (beats min21) 28 (216 to 0) 100 (60–132)* 102 (83–140)#
Change in heart rate (%beats min21) 27 (213 to 0) 87 (42–112)* 78 (55–117)#
T-elevation (yes/no) 4/11 15/0* 15/0#
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the pig model is the closest to humans, our results do not
fully reflect similar responses in children. In particular, we
used newborn pigs. In humans, it was demonstrated that
T-wave elevation is age-dependent. In children aged 6–72
months, a significant negative linear correlation was found
between age and the maximal per cent increase in T-wave
amplitude.5 In adults, i.v. epinephrine caused flattening or
inversion of the T-wave.14 15 Thus, further clinical studies
in children are needed.
On the basis of our study results, an epinephrine-
containing LA solution and ECG control should be used
for the reliable detection of inadvertent intravascular LA
injection in children. Since a cannula placed in the epi-
dural (caudal), axillar, or other spaces easily can dislodge
into a vessel, particularly when a syringe is changed,
epinephrine should be used for the full dose. Whether epi-
nephrine should be used only for the test dose or for the
full dose is a controversial issue.
In conclusion, this newborn animal model demonstrates
that T-elevation in the ECG during i.v. application of a
common test dose of bupivacaine is caused by epinephrine
addition. Whether these epinephrine responses are age-
dependent in children and whether higher doses of bupiva-
caine alone can cause similar ECG changes or not requires
further studies.
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